These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 10101034)
1. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034 [TBL] [Abstract][Full Text] [Related]
2. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation. Bayón Y; Alonso A; Sánchez Crespo M Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529 [TBL] [Abstract][Full Text] [Related]
3. Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells. Hernández M; de Arriba AF; Merlos M; Fuentes L; Crespo MS; Nieto ML Br J Pharmacol; 2001 Jan; 132(2):547-55. PubMed ID: 11159705 [TBL] [Abstract][Full Text] [Related]
5. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Wu KK Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite. Planavila A; Rodríguez-Calvo R; de Arriba AF; Sánchez RM; Laguna JC; Merlos M; Vazquez-Carrera M Mol Pharmacol; 2006 Apr; 69(4):1174-81. PubMed ID: 16421291 [TBL] [Abstract][Full Text] [Related]
8. Absence of nuclear factor kappaB inhibition by NSAIDs in hepatocytes. Callejas NA; Casado M; Boscá L; Martín-Sanz P Hepatology; 2002 Feb; 35(2):341-8. PubMed ID: 11826407 [TBL] [Abstract][Full Text] [Related]
9. Platelet antiaggregatory effect of triflusal in human whole blood. de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335 [TBL] [Abstract][Full Text] [Related]
10. Effects of the nuclear factor-kappaB inhibitors 2-hydroxy-4-trifluoromethylbenzoic acid and aspirin on micturition in rats with normal and inflamed bladder. Velasco C; Angelico P; Guarneri L; Leonardi A; Clarke DE; Testa R J Urol; 2001 Nov; 166(5):1962-8. PubMed ID: 11586268 [TBL] [Abstract][Full Text] [Related]
11. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo. Giuliano F; Mitchell JA; Warner TD J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873 [TBL] [Abstract][Full Text] [Related]
12. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes. de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046 [TBL] [Abstract][Full Text] [Related]
13. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Giuliano F; Warner TD J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520 [TBL] [Abstract][Full Text] [Related]
14. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377 [TBL] [Abstract][Full Text] [Related]
15. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. Liu CY; Lai YY; Lo CJ J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. Yamada M; Niki H; Yamashita M; Mue S; Ohuchi K J Pharmacol Exp Ther; 1997 May; 281(2):1005-12. PubMed ID: 9152412 [TBL] [Abstract][Full Text] [Related]
17. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Giuliano F; Warner TD Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826 [TBL] [Abstract][Full Text] [Related]
19. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells. Kim BH; Kang KS; Lee YS Toxicol Lett; 2004 Apr; 150(2):191-201. PubMed ID: 15093674 [TBL] [Abstract][Full Text] [Related]
20. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]